PLA2G7 and cardiovascular disorder: To date, much attention has focused on changes in circulating Lp-PLA2 and disease (arising from epidemiological studies), and has highlighted that Lp-PLA2 is upregulated in conditions of obesity, inflammation and cardiovascular disease (CVD) [4–7].